Our findings also show that in addition to donors with KIR/HLA match structure, the KIR B/x haplotype, in the absence of KIR2DS2 and KIR2DS1, is associated with more AML relapse. This evidence concerns the gene KIR3DL1 and acute myeloid leukemia.